Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.62 USD | +1.69% | -2.16% | -32.34% |
04-09 | Harvard Bioscience Reducing Headcount | MT |
04-09 | Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth | CI |
Sales 2024 * | 114M 156M | Sales 2025 * | 126M 172M | Capitalization | 157M 215M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | 3M 4.1M | EV / Sales 2024 * | 1.38 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.25 x |
P/E ratio 2024 * |
-724
x | P/E ratio 2025 * |
48.3
x | Employees | 404 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.72% |
Latest transcript on Harvard Bioscience, Inc.
1 day | +1.69% | ||
1 week | -2.16% | ||
Current month | -14.62% | ||
1 month | -13.81% | ||
3 months | -20.61% | ||
6 months | -16.01% | ||
Current year | -32.34% |
Managers | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Jennifer Cote
DFI | Director of Finance/CFO | 52 | 22-04-30 |
David Balcom
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Alan Edrick
BRD | Director/Board Member | 56 | 19-09-02 |
Bertrand Loy
BRD | Director/Board Member | 58 | 14-11-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.37% | 4 M€ | -5.15% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.62 | +1.69% | 55,311 |
24-04-25 | 3.56 | -3.52% | 65,306 |
24-04-24 | 3.69 | -0.81% | 63,556 |
24-04-23 | 3.72 | +0.54% | 92,096 |
24-04-22 | 3.7 | 0.00% | 90,516 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.34% | 157M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- HBIO Stock